Stryker Inventory 2010-2024 | SYK

Stryker inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • Stryker inventory for the quarter ending September 30, 2024 was $5.292B, a 8.38% increase year-over-year.
  • Stryker inventory for 2023 was $4.843B, a 21.23% increase from 2022.
  • Stryker inventory for 2022 was $3.995B, a 20.55% increase from 2021.
  • Stryker inventory for 2021 was $3.314B, a 5.15% decline from 2020.
Stryker Annual Inventory
(Millions of US $)
2023 $4,843
2022 $3,995
2021 $3,314
2020 $3,494
2019 $2,980
2018 $2,955
2017 $2,465
2016 $2,030
2015 $1,639
2014 $1,588
2013 $1,422
2012 $1,265
2011 $1,283
2010 $1,057
2009 $943
Stryker Quarterly Inventory
(Millions of US $)
2024-09-30 $5,292
2024-06-30 $5,044
2024-03-31 $5,026
2023-12-31 $4,843
2023-09-30 $4,883
2023-06-30 $4,593
2023-03-31 $4,333
2022-12-31 $3,995
2022-09-30 $3,883
2022-06-30 $3,749
2022-03-31 $3,525
2021-12-31 $3,314
2021-09-30 $3,434
2021-06-30 $3,431
2021-03-31 $3,473
2020-12-31 $3,494
2020-09-30 $3,459
2020-06-30 $3,442
2020-03-31 $3,359
2019-12-31 $2,980
2019-09-30 $3,269
2019-06-30 $3,198
2019-03-31 $3,064
2018-12-31 $2,955
2018-09-30 $2,893
2018-06-30 $2,740
2018-03-31 $2,664
2017-12-31 $2,465
2017-09-30 $2,454
2017-06-30 $2,279
2017-03-31 $2,172
2016-12-31 $2,030
2016-09-30 $2,092
2016-06-30 $1,989
2016-03-31 $1,768
2015-12-31 $1,639
2015-09-30 $1,665
2015-06-30 $1,619
2015-03-31 $1,582
2014-12-31 $1,588
2014-09-30 $1,666
2014-06-30 $1,587
2014-03-31 $1,498
2013-12-31 $1,422
2013-09-30 $1,404
2013-06-30 $1,345
2013-03-31 $1,323
2012-12-31 $1,265
2012-09-30 $1,315
2012-06-30 $1,289
2012-03-31 $1,318
2011-12-31 $1,283
2011-09-30 $1,297
2011-06-30 $1,284
2011-03-31 $1,221
2010-12-31 $1,057
2010-09-30 $1,035
2010-06-30 $968
2010-03-31 $961
2009-12-31 $943
2009-09-30 $977
2009-06-30 $992
2009-03-31 $990
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.728B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.382B 25.94
Boston Scientific (BSX) United States $134.855B 38.77
EssilorLuxottica (ESLOY) France $111.549B 0.00
Medtronic (MDT) Ireland $108.676B 16.14
Haleon (HLN) United Kingdom $43.230B 28.09
Lonza Group Ag (LZAGY) Switzerland $42.368B 0.00
GE HealthCare Technologies (GEHC) United States $37.464B 19.43
ResMed (RMD) United States $35.759B 29.39
Terumo (TRUMY) Japan $29.367B 41.47
Koninklijke Philips (PHG) Netherlands $24.796B 18.98
Zimmer Biomet Holdings (ZBH) United States $21.580B 13.74
Insulet (PODD) United States $18.378B 73.18
Baxter (BAX) United States $16.844B 10.96
Smith & Nephew SNATS (SNN) United Kingdom $10.947B 0.00
BellRing Brands (BRBR) United States $9.886B 39.63
Bio-Rad Laboratories (BIO) United States $9.115B 30.98
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.071B 14.11
TG Therapeutics (TGTX) United States $5.378B 0.00
Haemonetics (HAE) United States $4.291B 20.94
Prestige Consumer Healthcare (PBH) United States $4.157B 20.67
ICU Medical (ICUI) United States $4.134B 39.36
Perrigo (PRGO) Ireland $3.694B 10.88
Envista Holdings (NVST) United States $3.681B 27.42
Agios Pharmaceuticals (AGIO) United States $3.167B 0.00
Neogen (NEOG) United States $3.159B 36.45
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.782B 17.84
QuidelOrtho (QDEL) United States $2.548B 16.40
LeMaitre Vascular (LMAT) United States $2.380B 57.85
Warby Parker (WRBY) United States $2.366B 0.00
Green Thumb Industries (GTBIF) United States $1.977B 34.59
AtriCure (ATRC) United States $1.740B 0.00
InMode (INMD) Israel $1.552B 9.34
AdaptHealth (AHCO) United States $1.331B 9.51
Curaleaf Holdings (CURLF) Canada $1.293B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.253B 0.00
BioLife Solutions (BLFS) United States $1.178B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.97
Owens & Minor (OMI) United States $0.943B 7.37
National Vision Holdings (EYE) United States $0.910B 30.40
CeriBell (CBLL) United States $0.904B 0.00
Evolus (EOLS) United States $0.826B 0.00
Capricor Therapeutics (CAPR) United States $0.809B 0.00
VAREX IMAGING (VREX) United States $0.679B 30.02
Surmodics (SRDX) United States $0.561B 0.00
Cresco Labs (CRLBF) United States $0.561B 0.00
Verano Holdings (VRNOF) United States $0.554B 0.00
Quanterix (QTRX) United States $0.450B 0.00
Omeros (OMER) United States $0.448B 0.00
Canopy Growth (CGC) Canada $0.407B 0.00
ZimVie (ZIMV) United States $0.379B 31.95
Valneva SE (VALN) France $0.359B 0.00
Viemed Healthcare (VMD) United States $0.339B 32.26
Biote (BTMD) United States $0.334B 7.31
Sanara MedTech (SMTI) United States $0.326B 0.00
Cerus (CERS) United States $0.310B 0.00
OraSure Technologies (OSUR) United States $0.287B 19.25
Zynex (ZYXI) United States $0.258B 54.07
Aurora Cannabis (ACB) Canada $0.236B 0.00
TerrAscend (TSNDF) Canada $0.224B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.12
High Tide (HITI) Canada $0.215B 89.00
MacroGenics (MGNX) United States $0.201B 0.00
Sanuwave Health (SNWV) United States $0.189B 2.67
Jin Medical (ZJYL) China $0.166B 0.00
Organigram Holdings (OGI) Canada $0.164B 0.00
Brainsway (BWAY) Israel $0.164B 98.40
Zevia PBC (ZVIA) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.147B 18.50
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Fonar (FONR) United States $0.104B 11.75
Quipt Home Medical (QIPT) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.10
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.079B 0.00
Rockwell Medical (RMTI) United States $0.071B 36.67
Exagen (XGN) United States $0.069B 0.00
Modular Medical (MODD) United States $0.067B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.061B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.053B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Cytosorbents (CTSO) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00